An enlarged prostate is a condition where the prostate gland grows large enough to squeeze the urethra and interfere with urination. Medically called benign prostatic hyperplasia (BPH), it affects about half of men in their 50s, roughly 70% of men in their 60s, and around 80% of men over 70. “Benign” means the growth isn’t cancer, though the urinary symptoms it causes can significantly affect daily life.
Why the Prostate Grows
The prostate sits just below the bladder and wraps around the urethra, the tube that carries urine out of the body. It’s roughly walnut-sized in younger men, but hormonal changes over decades cause it to enlarge. The key driver is a potent form of testosterone called DHT. Enzymes inside the prostate convert regular testosterone into DHT, and in men with BPH, the activity of these enzymes is about seven times higher than in normal prostate tissue. This ramped-up DHT production fuels cell growth.
Estrogen also plays a role. As men age, the balance between testosterone and estrogen shifts. Enzyme activity that produces estrogen locally within the prostate increases in BPH tissue, particularly in areas that are actively growing. The interaction between different cell layers in the prostate, the inner lining and the surrounding structural tissue, creates feedback loops where growth signals from one layer stimulate the other, gradually building tissue mass over years and decades.
How It Affects Urination
As the prostate expands, it compresses the urethra like a clamp tightening around a garden hose. The bladder has to work harder to push urine through this narrower opening. Early on, the bladder muscle compensates by getting thicker and stronger, but over time it weakens from the chronic strain. When that happens, the bladder may not empty completely each time you urinate.
The symptoms this creates tend to fall into two categories. Obstructive symptoms include a weak or stop-and-start urine stream, straining to begin urinating, and the feeling that your bladder hasn’t fully emptied. Storage symptoms include needing to urinate frequently (especially at night), sudden strong urges, and sometimes leaking before you reach a bathroom. Most men with BPH experience a mix of both types, and the symptoms typically develop so gradually that they seem normal until they become disruptive.
What Happens if It Goes Untreated
Mild BPH doesn’t always need treatment, but chronic obstruction that worsens over time can lead to real complications. Urinary retention, where you suddenly can’t urinate at all, is one of the more serious outcomes and requires emergency catheterization. Incomplete bladder emptying also raises the risk of urinary tract infections and bladder stones, since stagnant urine becomes a breeding ground for bacteria. In the most severe cases, prolonged back-pressure from a bladder that can’t drain properly causes kidney damage.
Lifestyle Changes That Help
For mild to moderate symptoms, simple adjustments can make a noticeable difference. Cutting back on fluids one to two hours before bedtime helps reduce nighttime trips to the bathroom. Tracking how much you drink and how often you urinate can reveal whether high fluid intake is partly responsible for your frequency. Caffeine is a known irritant: higher coffee or total caffeine intake is associated with greater odds of BPH symptoms getting worse over time. Alcohol, especially in the evening, can have a similar effect by increasing urine production and relaxing the bladder.
Medications for BPH
When symptoms interfere with sleep, work, or daily comfort, two main classes of medication are used. They work in fundamentally different ways.
Alpha Blockers
These medications relax the smooth muscle in the prostate and bladder neck, widening the channel so urine flows more easily. They don’t shrink the prostate itself. Relief typically begins within days to a couple of weeks. Common side effects include dizziness (especially when standing up quickly), nasal congestion, and occasionally issues with ejaculation.
DHT-Blocking Medications
These work by blocking the enzyme that converts testosterone into DHT inside the prostate. With less DHT driving growth, the prostate gradually shrinks. The trade-off is patience: it takes about six months to reach full effect. The most commonly reported side effects involve sexual function, including reduced sex drive, erectile difficulties, and changes in ejaculation. A small number of men report that these sexual side effects persist even after stopping the medication.
For men with both obstructive and storage symptoms, current guidelines from the American Urological Association note that an alpha blocker can be started first, with a second medication added if storage symptoms (urgency, frequency) don’t improve enough on their own. Combination therapy using both an alpha blocker and a DHT blocker together is common for men with larger prostates or more severe symptoms.
Surgical and Minimally Invasive Options
When medications aren’t enough, or when the prostate is simply too large for drugs to manage, procedures that physically remove or reduce prostate tissue become the next step.
The traditional gold standard is transurethral resection of the prostate, commonly called TURP. A surgeon threads an instrument through the urethra and shaves away excess prostate tissue from the inside. It works well for prostates under about 60 grams, which covers most cases. For larger prostates, TURP carries a higher risk of bleeding and incomplete removal.
A newer laser-based procedure called HoLEP (holmium laser enucleation) has become an alternative gold standard. It works regardless of prostate size, which makes it especially useful for larger glands. Studies comparing the two for prostates between 60 and 100 grams show that HoLEP produces statistically significant improvements in symptoms at three months, with shorter catheter times and less need for post-operative irrigation. That said, in the hands of experienced surgeons, TURP remains a solid option even for larger prostates.
Less invasive office-based procedures also exist for men who want symptom relief with lower risk and faster recovery. These options use small implants or targeted energy to open the urethral channel without removing tissue. They generally offer more modest symptom improvement than TURP or HoLEP, but recovery is measured in days rather than weeks, and the risk of sexual side effects is lower. They’re best suited for men with mild to moderate symptoms and smaller prostates.
How Symptoms Are Measured
If you visit a doctor about urinary changes, you’ll likely be asked to fill out a standardized symptom questionnaire called the IPSS (International Prostate Symptom Score). It rates seven symptoms on a scale, producing a total score from 0 to 35. Mild symptoms fall in the 1 to 7 range, moderate from 8 to 19, and severe from 20 to 35. Your score helps guide whether watchful waiting, medication, or a procedure makes the most sense. It’s also used at follow-up visits to track whether treatment is actually working.
Additional tests often include a urine flow rate measurement, an ultrasound to check how much urine remains in your bladder after you go, and sometimes a blood test to rule out other conditions. The goal is to match the intensity of treatment to how much the symptoms actually bother you, not just how big the prostate measures on a scan. A large prostate with minimal symptoms may need nothing more than monitoring, while a moderately enlarged one causing nightly disruptions may warrant treatment right away.